Clinic
Inspira Medical Centers, INC.
Inspira Medical Centers, INC. was paid $3.21M by Medicaid between Oct 2023 and Nov 2024, across 124 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoINSPIRA MEDICAL CENTERS, INC.
SALEM, NJ 08079
SALEM, NJ 08079
33aNPI1437832201assigned 08/09/2023
33bProvider typePhysical Therapy Clinic/Center
28Total paid$3.21M
24GClaims67,548
24DCodes billed124
24AFirst – last monthOct 2023 – Nov 2024
Compared with peers
Next to other Physical Therapy Clinic/Center providers in New Jersey
Rank by total paid#4 of 92
Median peer was paid$61K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 17,255 | $726K | |
| 2024incomplete | 50,293 | $2.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 3,737 | 3,416 | $1.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 2,293 | 2,068 | $702K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 2,208 | 1,922 | $689K |
| G0378 | Hospital observation service, per hour | 6.4% | 415 | 294 | $206K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 760 | 727 | $90K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 1,518 | 1,327 | $49K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 2,001 | 459 | $49K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 327 | 314 | $35K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 1,984 | 1,661 | $34K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 444 | 416 | $27K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 279 | 263 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,311 | 1,156 | $14K |
112 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 620 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 924 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 502 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 764 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 742 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 964 | $11K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 367 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 589 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 225 | $9K |
| OP259 | <1% | 4,100 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 89 | $6K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 277 | $6K |
| 72110 | <1% | 208 | $6K | |
| OP710 | <1% | 264 | $6K | |
| 97161 | <1% | 224 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 278 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 818 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,541 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,106 | $5K |
| 73630 | <1% | 316 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 53 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 78 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,449 | $4K |
| 73130 | <1% | 276 | $4K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 33 | $4K |
| 73564 | <1% | 152 | $3K | |
| 73030 | <1% | 223 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 570 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 135 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 83 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 212 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 651 | $2K |
| 84484 | <1% | 1,062 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 28 | $2K |
| 73610 | <1% | 165 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 212 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 41 | $2K |
| OP250 | <1% | 1,508 | $2K | |
| 86901 | <1% | 101 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 75 | $2K |
| 90715 | <1% | 107 | $2K | |
| 84703 | <1% | 1,260 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 579 | $1K |
| 96376 | <1% | 218 | $1K | |
| 82553 | <1% | 862 | $1K | |
| 83880 | <1% | 254 | $1K | |
| 80076 | <1% | 915 | $1K | |
| 82962 | <1% | 1,410 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 55 | $1K |
| 86850 | <1% | 98 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 275 | $959.07 |
| 81001 | <1% | 2,048 | $912.82 | |
| 86900 | <1% | 101 | $910.45 | |
| 82550 | <1% | 903 | $872.97 | |
| 83690 | <1% | 861 | $863.82 | |
| 73562 | <1% | 97 | $855.63 | |
| 83735 | <1% | 827 | $807.87 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 134 | $765.08 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 282 | $736.52 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 228 | $720.97 |
| 73110 | <1% | 43 | $563.45 | |
| 74018 | <1% | 50 | $560.20 | |
| 97010 | <1% | 358 | $539.58 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 173 | $538.21 |
| 88342 | <1% | 14 | $519.36 | |
| C1767 | Generator, neurostimulator (implantable), non-rechargeable | <1% | 128 | $503.60 |
| 73502 | <1% | 43 | $464.39 | |
| 77080 | <1% | 14 | $449.63 | |
| 85027 | <1% | 173 | $423.87 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 321 | $388.82 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 221 | $369.18 |
| J3490 | Unclassified drugs | <1% | 1,344 | $342.83 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 797 | $342.16 |
| 93971 | <1% | 12 | $267.34 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 331 | $263.57 |
| 87420 | <1% | 70 | $252.19 | |
| 85610 | <1% | 267 | $251.72 | |
| 85379 | <1% | 171 | $236.00 | |
| 80061 | Lipid panel | <1% | 112 | $179.53 |
| 85730 | <1% | 129 | $165.58 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 108 | $137.34 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 833 | $122.99 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 329 | $119.51 |
| OP637 | <1% | 698 | $117.47 | |
| 83605 | <1% | 61 | $114.96 | |
| 97014 | <1% | 55 | $99.47 | |
| J2704 | Injection, propofol, 10 mg | <1% | 298 | $87.82 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 255 | $83.45 |
| 87081 | <1% | 46 | $74.45 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 285 | $72.78 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 81 | $68.96 |
| 84100 | <1% | 84 | $57.46 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 431 | $46.65 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 125 | $46.11 |
| 82803 | <1% | 16 | $45.89 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 35 | $45.47 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 79 | $41.74 |
| 82248 | <1% | 27 | $38.72 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 181 | $37.01 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 13 | $26.40 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 33 | $16.08 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 40 | $14.78 |
| 87040 | <1% | 17 | $11.79 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 210 | $11.44 |
| A9270 | Non-covered item or service | <1% | 276 | $4.77 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 56 | $4.74 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 153 | $4.03 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 35 | $3.52 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 35 | $3.46 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 35 | $1.72 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 15 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPELINO, WILLIAM (SR. VICE PRESIDENT & CFO)